Ampio Pharmaceuticals (AMPE, $2.30): Incredible Run Projected to Stop in January 2021

A big year for pharmaceuticals, 2020 has more surprises in store for Ampio Pharmaceuticals (AMPE, $2.30). A January 2021 $2.00 call implies a high volatility, which points to a possible near future sell-off, which would lead to the price falling. The stock rose 200% in the last month, leading to an absolute maximum of $2.41 last week. This surge followed an announcement of Ampio’s new COVID 19 treatment successfully moving toward a Phase 2 clinical trial after the Safety Monitoring Committee gave it the green light. Although the stock showed incredible results from December 20, 2019 to December 20, 2020 with a $2.30 (+370.77%) surge in price, a huge 6.613M (+312.41%) rise is volume, and an impressive $445.98M (+476.66%) change in market capitalization, the jury is still out. Technical indicators seem to suggest a short-term uptrend while fundamental ratings foreshadow a serious downtrend in the future. Certainly supporting the latter is Ampio’s notable price-to-book ratio: an inflated whopping 41.33, (+158.56% change since December 2019), indicating the company might be heavily overvalued. A very volatile stock, predictions on Ampio are to be watched carefully. 

Contributor

Serhii Bondarenko|Expert

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.